Skip to main content
Clinical Trials/CTRI/2012/12/003212
CTRI/2012/12/003212Completed未知

Maternal vitamin B12, folate and homocysteine as determinants of gestational diabetes, fetal growth and inter-generational programming of diabesity

Indian Council of Medical Research0 sites700 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
700

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Adolescents in the Pune Maternal Nutrition Study, who agree to participate (assent), and whose parent/s give informed, written consent

Exclusion Criteria

  • 1. Plasma vitamin B12 concentration <100pmol/L
  • 2. Hemoglobin concentration <7g/dL
  • 3. Severe developmental disability likely to interfere with marriage and reproduction
  • 4. Serious systemic illness (that would prohibit participation in any clinical trial, e.g. malignancy, reproductive system disorder leading to infertility, congenital or acquired cardiovascular disease with NYHA Functional Classification III or IV)
  • 5. Treatment with drugs interfering with one-carbon metabolism (e.g. folate antagonists: phenytoin, valproic acid, carbamazepine, trimethoprim, methotrexate; B12 antagonists: metformin, PPIs)
  • 6. Treatment with hematinics (iron and/ or B group of vitamins) for more than 30 days

Investigators

Similar Trials